Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Parsons

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Chest|February 21, 2016
Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung CancerAnil Vachani, Duncan H Whitney, Edward C Parsons, et al.
Investigative Radiology|October 8, 2009
Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibilityJosef Vymazal, Elmar Spuentrup, Gerardo Cardenas-Molina, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 15, 2022
Pachymetric Assessment After EpiSmart<sup>®</sup> Epithelium-on Cross-Linking for Keratoconus and Post-Surgical EctasiaNeel S Vaidya, Arvin Daneshmand, Randy J Epstein, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2005
Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agentElmar Spuentrup, Marcus Katoh, Andrea J Wiethoff, et al.
Cornea|April 10, 2026
A Multicenter, Randomized, Double-Masked, Sham-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-on Corneal Crosslinking in Keratoconus Subjects 8 to 45 Years of Age: Baseline Endothelial StudiesMichael Wellington Belin, Janet DeMarchi, Beth Ann Benetz, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trialKarl Rickels, Sanjay Mathew, Michael D Banov, et al.
JAMA Ophthalmology|June 2, 2017
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation StudyTimothy L Jackson, David Boyer, David M Brown, et al.
Circulation|March 2, 2005
Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agentElmar Spuentrup, Arno Buecker, Marcus Katoh, et al.
European Journal of Radiology|May 15, 2007
A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery diseaseRobert McGregor, Josef Vymazal, Manuel Martinez-Lopez, et al.
Investigative Radiology|July 11, 2007
Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agentElmar Spuentrup, Marcus Katoh, Arno Buecker, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Chest|February 21, 2016
Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung CancerAnil Vachani, Duncan H Whitney, Edward C Parsons, et al.
Investigative Radiology|October 8, 2009
Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibilityJosef Vymazal, Elmar Spuentrup, Gerardo Cardenas-Molina, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 15, 2022
Pachymetric Assessment After EpiSmart<sup>®</sup> Epithelium-on Cross-Linking for Keratoconus and Post-Surgical EctasiaNeel S Vaidya, Arvin Daneshmand, Randy J Epstein, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2005
Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agentElmar Spuentrup, Marcus Katoh, Andrea J Wiethoff, et al.
Cornea|April 10, 2026
A Multicenter, Randomized, Double-Masked, Sham-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-on Corneal Crosslinking in Keratoconus Subjects 8 to 45 Years of Age: Baseline Endothelial StudiesMichael Wellington Belin, Janet DeMarchi, Beth Ann Benetz, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trialKarl Rickels, Sanjay Mathew, Michael D Banov, et al.
JAMA Ophthalmology|June 2, 2017
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation StudyTimothy L Jackson, David Boyer, David M Brown, et al.
Circulation|March 2, 2005
Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agentElmar Spuentrup, Arno Buecker, Marcus Katoh, et al.
European Journal of Radiology|May 15, 2007
A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery diseaseRobert McGregor, Josef Vymazal, Manuel Martinez-Lopez, et al.
Investigative Radiology|July 11, 2007
Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agentElmar Spuentrup, Marcus Katoh, Arno Buecker, et al.
Pageof 3